The Incidence of EGFR-Activating Mutations in Bone Metastases of Lung Adenocarcinoma-Reference-Cited by-同舟云学术

The Incidence of EGFR-Activating Mutations in Bone Metastases of Lung Adenocarcinoma

Published:2013-07-14 Issue:1 Volume:20 Page:107-112
ISSN:1219-4956
Container-title:Pathology & Oncology Research
language:en
Short-container-title:Pathol. Oncol. Res.

Author:

Krawczyk Paweł,Nicoś Marcin,Ramlau Rodryg,Powrózek Tomasz,Wojas-Krawczyk Kamila,Sura Sylwia,Jarosz Bożena,Szumiło Justyna,Warda Edward,Mazurkiewicz Tomasz,Sawicki Marek,Milanowski Janusz

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine,Pathology and Forensic Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12253-013-9667-4.pdf

Reference17 articles.

1. Jemal A, Bray F, Center MM et al (2011) Global cancer statistic. CA Cancer J Clin 61:69–90

2. Kadara H, Kabbout M, Wistuba II (2011) Pulmonary adenocarcinoma: a renewed entity in 2012. Respirology 17:50–65

3. Kalikaki A, Koutsopoulos A, Trypaki M et al (2008) Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC. Br J Cancer 99:923–929

4. Petrelli F, Borgonovo K, Cabiddu M et al (2012) Efficacy of EGFR tyrosine kinase inhibitors in patients with EGFR-mutated non-small-cell lung cancer: a meta-analysis of 13randomized trials. Clin Lung Cancer 13:107–114

5. Italiano A, Vandenbos FB, Otto J et al (2006) Comparison of the epidermal growth factor receptor gene and protein in primary non-small-cell-lung cancer and metastatic sites: implications for treatment with EGFR-inhibitors. Ann Oncol 17:981–985

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From Tumor to Bone: Growth Factor Receptors as Key Players in Cancer Metastasis;Frontiers in Bioscience-Landmark;2024-05-13

2. Intersecting Paths: Unraveling the Complex Journey of Cancer to Bone Metastasis;Biomedicines;2024-05-13

3. Bone metastasis in non-small-cell lung cancer: genomic characterization and exploration of potential targets;Therapeutic Advances in Medical Oncology;2024-01

4. Comprehensive analysis of prediction of the EGFR mutation and subtypes based on the spinal metastasis from primary lung adenocarcinoma;Frontiers in Oncology;2023-04-18

5. Radiomics of Spinal Metastases Originating From Primary Nonsmall Cell Lung Cancer or Breast Cancer and Ability to Predict Epidermal Growth Factor Receptor Mutation/Ki-67 Levels;Journal of Computer Assisted Tomography;2023-03-09